NCT05582941View on ClinicalTrials.gov

Biomarkers of Cognitive Impairment in Blood Cells

CompletedOBSERVATIONAL
Enrollment

48

Participants

Timeline

Start Date

April 1, 2022

Primary Completion Date

May 31, 2023

Study Completion Date

May 31, 2023

Conditions
Mild Cognitive Impairment Due to Alzheimer's DiseaseDementia Due to Alzheimer's Disease (Disorder)
Interventions
OTHER

No intervention will be performed.

No intervention will be performed.

Trial Locations (1)

07122

University of the Balearic Islands, Palma, Mallorca

All Listed Sponsors
collaborator

Fundació d'investigació Sanitària de les Illes Balears

OTHER_GOV

collaborator

Consorcio Centro de Investigación Biomédica en Red (CIBER)

OTHER_GOV

lead

University of the Balearic Islands

OTHER